- Joined
- Dec 17, 2007
- Messages
- 3,714
- Reaction score
- 5,232
The rationale for this trial is truly puzzling.I mean duh
The rationale for this trial is truly puzzling.I mean duh
They are still looking for that reproducible XRT/IO magic that has dominated radonc translational work for over a decade now. They rationalized the failure of the concurrent XRT/IO trials by condemning ENI as a detriment to TILs.The rationale for this trial is truly puzzling.
Well, delivering radiation and chemo is not done in my country anymore ( but since it used to be if radiotherapy really decline i think we might be able to compensate that way).Depends on what part of Europe - while it's not done in America, there's a good chunk of countries where Oncologists deliver both radiation and chemo...unless we cure cancer, that's a pretty safe gig.
I'm pretty sure they were hoping that treating primary with SBRT would prime IO response to regional disease. It all goes back to this....You can criticize giving IO to treat the nodes, sure. Can you also criticize 25 Gy preop? What purpose does this serve beyond limiting the ability to use RT for recurrent disease?
To be honest , any medical specialty in Europe make way way way less money lolNo, it´s not that bad. You will however not make the figures that many of the US colleagues make. 🙂
It's important to know however which part of Europe you want to work at, which again has to do with the language(s) you speak.
To be honest , any medical specialty in Europe make way way way less money lol
(few exceptions but it is still the rule).
In some countries it is the best paying specialty like in France but depends on your pratice.
While having a good salary is important to me i think going into radonc and expecting to have the best salary is still a bad move considering the job market.
More worried about mobility and being stuck in a public setting forever
I'm pretty sure they were hoping that treating primary with SBRT would prime IO response to regional disease. It all goes back to this....
![]()
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas - PubMed
The combination of PD-1 blockade and localized radiation therapy results in long-term survival in mice with orthotopic brain tumors. These studies provide strong preclinical evidence to support combination trials in patients with GBM.pubmed.ncbi.nlm.nih.gov
and this...
Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody - PMC
This study tested the hypothesis that the type of dose-fractionation regimen determines the ability of radiotherapy to synergize with anti-CTLA-4 antibody. TSA mouse breast carcinoma cells were injected s.c. into syngeneic mice at two separate ...www.ncbi.nlm.nih.gov
and any number of preclinical IO/XRT stuff starting around 2010
I mean duh
from my understanding, treating patients on a trial does not prevent malpractice suits...Should have gone to jail for this study.
from my understanding, treating patients on a trial does not prevent malpractice suits...
i would add that i know someone who ran a very small de-escalation trial in these patients and had some bad outcomes. the trial did not get published, but they were scared about getting sued.
Is this true? And just legally, I know people can sue, but what does the consent form protect you from if not this?from my understanding, treating patients on a trial does not prevent malpractice suits...
i would add that i know someone who ran a very small de-escalation trial in these patients and had some bad outcomes. the trial did not get published, but they were scared about getting sued.
The consent form protects you from bad humors, haints, JACHO, feelings of venality, that sort of thing.Is this true? And just legally, I know people can sue, but what does the consent form protect you from if not this?
That's always been the approach. Just easier for med onc. Cis/neda/carbo/oxali.... platin. Cycle rinse and repeat. Meta-analysis time.Current research approach is to run trials until you get a positive trial with your desired outcome.
Brady was very supportive of medical students and residents. Always willing to make a phone call, give them an authorship, write a glowing letter etc.Luther Brady sliced and diced authorships in his papers and textbook however the hell he wanted 🙂 and as a junior author, our job was to stay quiet
Brady was very supportive of medical students and residents. Always willing to make a phone call, give them an authorship, write a glowing letter.
180 degree turn after that. Paid faculty bottom dollar and would use IMGs (with no us residency training) as faculty. He had a number of his own private satellite practices that he staffed with hahnmenan faculty on
hanheman’s dime. Was forced out as chair for this and other unscripulous financial practices. Rumor was that he would face criminal charges at one point. I have also been told by senior faculty that his research was basically totally made up.
What a great historical foundation we builtBrady was very supportive of medical students and residents. Always willing to make a phone call, give them an authorship, write a glowing letter.
180 degree turn after that. Paid faculty bottom dollar and would use IMGs (with no us residency training) as faculty. He had a number of his own private satellite practices that he staffed with hahnmenan faculty on
hanheman’s dime. Was forced out as chair for this and other unscripulous financial practices. Rumor was that he would face criminal charges at one point. I have also been told by senior faculty that his research was basically totally made up.
Next top doctorBrady was very supportive of medical students and residents. Always willing to make a phone call, give them an authorship, write a glowing letter.
180 degree turn after that. Paid faculty bottom dollar and would use IMGs (with no us residency training) as faculty. He had a number of his own private satellite practices that he staffed with hahnmenan faculty on
hanheman’s dime. Was forced out as chair for this and other unscripulous financial practices. Rumor was that he would face criminal charges at one point. I have also been told by senior faculty that his research was basically totally made up.
Next top doctor
What a great historical foundation we built
I do wonder. Are we as bad or worse in terms of criminality and exploration compared to others?
The bird is spicy today
The bird is spicy today
I walked away in 2020... I know there's been a gradual exodus away from ASTRO on the part of community physicians for years, but they haven't cared about it (yet!). They did call me when i cancelled my membership after over a decade post residency, but I'm pretty sure whatever i said fell on deaf ears.Im happy to see it might be a movement. Maybe if enough people leave it will motivate them to wipe the leadership and start over with a less conflicted group.
Im not sure how a Rad Onc could support that policy statement, I guess that's why no one's name is on it except the lobby group and... The Maryland Proton Center? LOL what.
I left years before that. No meaningful education beyond what I could access elsewhere. No initiatives that impacted my community practice favorably.I walked away in 2020
I like how someone here called OLA mini-mental status scale
Maybe so, but I would much rather do OLA than take that 10-year re-cert abominationWhile we are on the gripe train.. this whole OLA bs is absolute funking useless. Garbage. Nothing to do with being a good radiation oncologist whatsoever. I read the mednet, keep up with pubs (thanks scihub) and generally have a high level of inquisitiveness. Does anyone care if we draw volumes correctly by asking stupid OLA questions? COME ON. If they cared, they'd have saved the online tumor board .com that went under (forgot the name). Oh well, what matters is the money keeps flowing.
NBPAS beckons. Some hospitals take it and more are on the way. CME or GTFO, screw the grifters.
OLA great. 5 am on the $&!;"er Monday morning half asleep and still able to answer those questions without a hitch.While we are on the gripe train.. this whole OLA bs is absolute funking useless. Garbage. Nothing to do with being a good radiation oncologist whatsoever. I read the mednet, keep up with pubs (thanks scihub) and generally have a high level of inquisitiveness. Does anyone care if we draw volumes correctly by asking stupid OLA questions? COME ON. If they cared, they'd have saved the online tumor board .com that went under (forgot the name). Oh well, what matters is the money keeps flowing.
NBPAS beckons. Some hospitals take it and more are on the way. CME or GTFO, screw the grifters.
OLA great. 5 am on the $&!;"er Monday morning half asleep and still able to answer those questions without a hitch.
Are you really griping about the difficulty of 2 OLA questions we get a week?
Nbpas is kind the betamax vs acr/ACP etc as VHS, no?Yeah, I'm griping. CME is sufficient. Can you imagine the overhead in the OLA program that could be, say I dunno, put towards some kind of better use? Like say.. producing high quality CME content for FREE for our beloved members?
Also, today's question cited a paper from 1986. 1986 ! The correct answer for them isn't the correct answer for my world when it comes to palliation. Ridiculous.. as if there is only one 'correct' way to deal with palliative situations. Bullshido.
Bottom line for me is.. NBPAS is much lower cost, and requires only CME after primary certification. Can you imagine paying 100 or less a year instead of 400 and not having to play the MOC game? I'm starting to believe this is way. My hospital said it will take NBPAS.
To walk away from the ABR and ASTRO fees and hoop jumping would be... amazing. If enough did so, how long before OLA disappears and CME comes back like a tsunami? Save this post, lets see if it ages well.
![]()
Nice, SBRT for OM fails again!